グリーンケミストリー市場：グリーンケミストリーへの取り組み、グリーンケミストリー・ソリューションプロバイダーの競合情勢、新たなメガトレンド、大手製薬会社の取り組み、企業プロファイル、主な促進要因と抑制要因

製薬会社が研究・製造プロセスでグリーンケミストリーを採用した使用事例は60以上知られており、グリーンケミストリー市場は着実なペースで進化していくと予想されます。

グリーンケミストリーには、有害物質を最小化または排除する化学製品やプロセスの設計、開発、導入が含まれます。製薬業界では、グリーンケミストリーは環境の持続可能性を促進し、化学合成の効率を向上させるために不可欠です。従来の医薬品製造はエネルギー集約型であり、再生不可能な資源に依存しているため、廃棄物が大量に発生し、処理にコストがかかります。例えば、世界の医薬品有効成分（API）の生産量は年間6,500万～1億キログラムと推定され、約100億キログラムの廃棄物が発生し、その処理費用は約200億米ドルに上ります。

製薬業界は世界の二酸化炭素排出量の約17％を占めており、その半分近くが原薬とその原料の製造に起因しています。環境への関心が高まる中、より環境に優しい製造方法を採用することが急務となっています。その結果、製薬会社は光化学、電気化学、生体触媒などの様々な技術を活用し、グリーンケミストリーの原則を業務に組み込んでいます。製薬業界では、生体触媒が化学合成におけるグリーンケミストリーの重要な応用例となっています。このアプローチは、製造時間の80％短縮、生産収率の向上、出発原料コストの99％以上の削減、精製工程における有機溶媒の使用廃止など、大きな利点を実証しています。

グリーンケミストリーは、有害物質への依存度の低減、コスト削減、プロセス効率の向上など、製薬業界にさまざまなメリットをもたらします。そのため、多くの製薬会社は持続可能な未来を確保するため、グリーンケミストリーにますます力を入れるようになっています。特に、AstraZeneca、BASF、Pfizerなどの企業は、2040年または2050年までにサプライチェーン全体の排出量を正味ゼロにすることを目指しています。こうした取り組みは、世界の規制基準に沿ったものであり、環境に優しい製品を求める消費者の需要の高まりに応えるものです。

企業がグリーンケミストリーや持続可能な技術への投資を増やしていることから、グリーンケミストリー市場は大幅な成長が見込まれ、医薬品開発と製造におけるより持続可能で責任ある未来への道が開かれます。

当レポートでは、世界のグリーンケミストリー市場について調査し、市場の概要とともに、グリーンケミストリー・ソリューションプロバイダーの競合情勢、新たなメガトレンド、大手製薬会社の取り組み、企業プロファイルなどを提供しています。

目次

セクションI：レポートの概要

第1章 範囲と目的

第2章 調査手法

セクションII：定性的な洞察

第3章 エグゼクティブサマリー

第4章 イントロダクション

セクションIII：市場概要

第5章 市場情勢：製薬業界におけるグリーンケミストリーの取り組み

第6章 市場情勢：グリーンケミストリー・ソリューションプロバイダー

セクションIV：企業プロファイルとケーススタディ

第7章 企業プロファイル

• 章の概要
• Amgen
• AstraZeneca
• Bristol Myers Squibb
• Codexis
• Johnson &Johnson
• Merck
• Merck KGaA
• Pfizer

第8章 ケーススタディ：大手製薬会社の取り組み

第5章 市場動向

第9章 グリーンケミストリー市場：進行中のメガ動向の概要

第10章 市場への影響分析：促進要因、抑制要因、機会、課題

第5章 付録

第11章 表形式のデータ

第12章 企業・団体一覧

List of Tables

• Table 5.1 List of Green Chemistry Initiatives: Information on Type of Green Chemistry Method Involved, Purpose of Initiative, Impact of Initiative, Type of Product Targeted, and Therapeutic Area of Drug Synthesized
• Table 5.2 List of Green Chemistry Initiatives Stakeholders
• Table 6.1 List of Key Companies Offering Green Chemistry Solutions
• Table 6.2 List of Companies Offering Green Chemistry Products and Platforms: Information on Type of Solution Offered, Type of Green Chemistry Method Involved and Pharmaceutical Application
• Table 6.3 List of Companies Offering Green Chemistry Services: Information on Type of Type of Green Chemistry Method Involved and Type of Service Offered
• Table 7.1 Amgen: Green Chemistry Initiatives
• Table 7.2 AstraZeneca: Green Chemistry Initiatives
• Table 7.3 Bristol Myers Squibb: Green Chemistry Initiatives
• Table 7.4 Codexis: Green Chemistry Initiatives
• Table 7.5 Johnson & Johnson: Green Chemistry Initiatives
• Table 7.6 Merck: Green Chemistry Initiatives
• Table 7.7 Merck KGaA: Green Chemistry Initiatives
• Table 7.8 Pfizer: Green Chemistry Initiatives
• Table 11.1 Green Chemistry Initiatives: Distribution by Type of Green Chemistry Method Involved
• Table 11.2 Green Chemistry Initiatives: Distribution by Purpose of Initiative
• Table 11.3 Green Chemistry Initiatives: Distribution by Therapeutic Area of API / Drug Synthesized
• Table 11.4 Green Chemistry Initiatives: Distribution by Impact of Initiative
• Table 11.5 Green Chemistry Initiatives Stakeholders: Distribution by Year of Establishment
• Table 11.6 Green Chemistry Initiatives Stakeholders: Distribution by Company Size
• Table 11.7 Green Chemistry Initiatives Stakeholders: Distribution by Location of Headquarters
• Table 11.8 Green Chemistry Solution Providers: Distribution by Year of Establishment
• Table 11.9 Green Chemistry Solution Providers: Distribution by Company Size
• Table 11.10 Green Chemistry Solution Providers: Distribution by Location of Headquarters
• Table 11.11 Green Chemistry Solution Providers: Distribution by Type of Solution Offered
• Table 11.12 Green Chemistry Solution Providers: Distribution by Type of Green Chemistry Method Involved
• Table 11.13 Green Chemistry Solution Providers: Distribution by Pharmaceutical Application
• Table 11.14 Green Chemistry Solution Providers: Distribution by Type of Service Offered

List of Figures

• Figure 1.1 Research Methodology: Project Methodology
• Figure 1.2 Research Methodology: Robust Quality Control
• Figure 3.1 Executive Summary: Market Landscape of Green Chemistry Initiatives in Pharma Industry
• Figure 3.2 Executive Summary: Market Landscape of Green Chemistry Solution Providers
• Figure 4.1 12 Principles of Green Chemistry
• Figure 5.1 Green Chemistry Initiatives: Distribution by Type of Green Chemistry Method Involved
• Figure 5.2 Green Chemistry Initiatives: Distribution by Purpose of Initiative
• Figure 5.3 Green Chemistry Initiatives: Distribution by Therapeutic Area of API / Drug Synthesized
• Figure 5.4 Green Chemistry Initiatives: Distribution by Impact of Initiative
• Figure 5.5 Green Chemistry Initiatives Stakeholders: Distribution by Year of Establishment
• Figure 5.6 Green Chemistry Initiatives Stakeholders: Distribution by Company Size
• Figure 5.7 Green Chemistry Initiatives Stakeholders: Distribution by Location of Headquarters
• Figure 6.1 Green Chemistry Solution Providers: Distribution by Year of Establishment
• Figure 6.2 Green Chemistry Solution Providers: Distribution by Company Size
• Figure 6.3 Green Chemistry Solution Providers: Distribution by Location of Headquarters
• Figure 6.4 Green Chemistry Solution Providers: Distribution by Type of Solution Offered
• Figure 6.5 Green Chemistry Solution Providers: Distribution by Type of Green Chemistry Method Involved
• Figure 6.6 Green Chemistry Solution Providers: Distribution by Pharmaceutical Application
• Figure 6.7 Green Chemistry Solution Providers: Distribution by Type of Service Offered
• Figure 9.1 Schematic Representation of Ongoing Megatrends

With more than 60 known use cases in which pharmaceutical companies have employed green chemistry in their research / manufacturing processes, the green chemistry market is anticipated to evolve at a steady pace.

Green chemistry involves the design, development and implementation of chemical products and processes that minimize or eliminate hazardous substances. In the pharmaceutical industry, green chemistry is vital for promoting environmental sustainability and improving the efficiency of chemical synthesis. Traditional drug manufacturing is energy-intensive and dependent on non-renewable resources, leading to significant waste generation and costly disposal. For example, global production of active pharmaceutical ingredients (APIs) is estimated to be 65 million to 100 million kilograms annually, generating approximately 10 billion kilograms of waste, with disposal costs around $20 billion.

The pharmaceutical industry is responsible for approximately 17% of global carbon emissions, with nearly half of this footprint stemming from the manufacturing of APIs and their raw materials. With increasing environmental concerns, there is an urgent need for industry to adopt greener production methods. Consequently, pharmaceutical companies are integrating green chemistry principles into their operations, utilizing various techniques such as photochemistry, electrochemistry, and biocatalysis. In the pharmaceutical industry, biocatalysis presents a significant application of green chemistry in chemical synthesis. This approach has demonstrated significant advantages, including reduction in manufacturing time by 80%, increase in production yield, decrease in the cost of starting materials by more than 99%, and elimination of the use of organic solvents during purification processes.

Green chemistry provides various benefits to the pharmaceutical industry, including reduced reliance on toxic substances, cost savings, and enhanced process efficiency. Thus, many pharmaceutical companies are increasingly focusing on green chemistry to ensure a sustainable future. Notably, firms such as AstraZeneca, BASF, and Pfizer are aiming for net-zero emissions across their supply chains by 2040 or 2050. These efforts align with global regulatory standards and respond to rising consumer demand for eco-friendly products.

As companies increasingly invest in green chemistry and sustainable technologies, the green chemistry market is expected to experience substantial growth, paving the way for a more sustainable and responsible future in drug development and manufacturing.

Research Coverage:

The report on green chemistry market covers the following elements:

• A project background providing an introduction to the context of the green chemistry market report and outlining various project objectives.
• An overview of the systematic research methodology employed to study the green chemistry industry, providing information on various assumptions, methodologies, and quality control measures used to ensure the accuracy and reliability of our findings.
• An infographic executive summary presenting key insights gathered during our research, providing a high-level perspective on the current state of green chemistry initiatives and green chemistry solution providers.
• A general overview of green chemistry, covering the 12 principles of green chemistry and prominent types of green chemistry methods. It also discusses various applications of green chemistry and addresses the challenges associated with its implementation.
• A comprehensive assessment of green chemistry initiatives within the pharma industry, based on several relevant parameters, such as the type of green chemistry method involved (biocatalysis, electrochemistry, photochemistry and others), purpose of initiative (research and manufacturing), therapeutic area of drug synthesized (cardiovascular disorders, infectious diseases, metabolic disorders, neurological disorders, oncological disorders, respiratory disorders and other disorders) and impact of initiative (energy efficient processes, improvement in yield, reduction in carbon footprint, reduction in manufacturing time, reduction in metal consumption, reduction in solvent-use, reduction in waste and others). Further, the report also provides information on the green chemistry initiatives stakeholders, along with analysis on various parameters, such as year of establishment, company size (in terms of employee count) and location of headquarters (region and country).
• An evaluation of the green chemistry solution providers, based on various relevant parameters, such as year of establishment, company size (in terms of employee count) and location of headquarters (region and country), type of solution offered (product, platform and service), type of green chemistry method involved (biocatalysis, electrochemistry and photochemistry), pharmaceutical application (research, manufacturing and other applications), and type of service offered (research, product / process development, manufacturing, scale-up and other services).
• Elaborate profiles of key companies in the green chemistry market. Each profile includes a brief overview of the company (year of establishment, location of headquarters, number of employees, management team and business segments), information on their green chemistry initiatives, recent developments and an informed future outlook.
• A comprehensive case study on big pharma initiatives that examine the impact of green chemistry practices on the pharmaceutical industry.
• A detailed assessment of various ongoing megatrends in the green chemistry industry, including rising demand for sustainable drug manufacturing, technological advancements in green chemistry practices, integration of continuous flow manufacturing with green chemistry practices, convergence of AI, data science with green chemistry applications, development of sustainability metrices, and many more.
• A detailed analysis identifying factors that influence the growth of green chemistry market. It includes insights into key drivers, potential restraints, emerging opportunities, and existing challenges in this domain.

Key Benefits of Buying this Report

• The report provides valuable insights into key green chemistry solution providers that are shaping the market landscape and driving sustainable practices in the industry.
• Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
• The report provides stakeholders with an overall outlook of the green chemistry market, featuring essential information on significant market drivers, barriers, opportunities, and challenges.

Example Companies Profiled

• Amgen
• AstraZeneca
• Bristol Myers Squibb
• Codexis
• Johnson & Johnson
• Merck
• Merck KGaA
• Pfizer

TABLE OF CONTENTS

SECTION I: REPORT OVERVIEW

1. SCOPE AND OBJECTIVES

• 1.1. Context
• 1.2. Project Objectives

2. RESEARCH METHODOLOGY

• 2.1. Project Methodology
• 2.2. Robust Quality Control Framework

SECTION II: QUALITATIVE INSIGHTS

3. EXECUTIVE SUMMARY

4. INTRODUCTION

• 4.1. An Overview of Green Chemistry
• 4.2. 12 Principles of Green Chemistry
• 4.3. Types of Green Chemistry Methods
• 4.4. Applications of Green Chemistry
• 4.5. Key Challenges in Green Chemistry Domain

SECTION III: MARKET OVERVIEW

5. MARKET LANDSCAPE: GREEN CHEMISTRY INITIATIVES IN PHARMA INDUSTRY

• 5.1. Methodology and Key Parameters
• 5.2. Green Chemistry Initiatives: Overall Market Landscape
  • 5.2.1. Analysis by Type of Green Chemistry Method Involved
  • 5.2.2. Analysis by Purpose of Initiative
  • 5.2.3. Analysis by Therapeutic Area of Drug Synthesized
  • 5.2.4. Analysis by Impact of Initiative
• 5.3. Green Chemistry Initiatives Stakeholders: Overall Market Landscape
  • 5.3.1. Analysis by Year of Establishment
  • 5.3.2. Analysis by Company Size
  • 5.3.3. Analysis by Location of Headquarters

6. MARKET LANDSCAPE: GREEN CHEMISTRY SOLUTION PROVIDERS

• 6.1. Methodology and Key Parameters
• 6.2. Green Chemistry Solution Providers: Overall Market Landscape
  • 6.2.1. Analysis by Year of Establishment
  • 6.2.2. Analysis by Company Size
  • 6.2.3. Analysis by Location of Headquarters
  • 6.2.4. Analysis by Type of Solution Offered
  • 6.2.5. Analysis by Type of Green Chemistry Method Involved
  • 6.2.6. Analysis by Pharmaceutical Application
  • 6.2.7. Analysis by Type of Service Offered

SECTION IV: COMPANY PROFILES AND CASE STUDY

7. COMPANY PROFILES

• 7.1. Chapter Overview
• 7.2. Amgen
  • 7.2.1. Company Overview
  • 7.2.2. Company Mission
  • 7.2.3. Company Footprint
  • 7.2.4. Management Team
  • 7.2.5. Contact Details
  • 7.2.6. Green Chemistry Initiatives
  • 7.2.7. Recent Developments and Future Outlook
• 7.3. AstraZeneca
  • 7.3.1. Company Overview
  • 7.3.2. Company Mission
  • 7.3.3. Company Footprint
  • 7.3.4. Management Team
  • 7.3.5. Contact Details
  • 7.3.6. Green Chemistry Initiatives
  • 7.3.7. Recent Developments and Future Outlook
• 7.4. Bristol Myers Squibb
  • 7.4.1. Company Overview
  • 7.4.2. Company Mission
  • 7.4.3. Company Footprint
  • 7.4.4. Management Team
  • 7.4.5. Contact Details
  • 7.4.6. Green Chemistry Initiatives
  • 7.4.7. Recent Developments and Future Outlook
• 7.5. Codexis
  • 7.5.1. Company Overview
  • 7.5.2. Company Mission
  • 7.5.3. Company Footprint
  • 7.5.4. Management Team
  • 7.5.5. Contact Details
  • 7.5.6. Green Chemistry Initiatives
  • 7.5.7. Recent Developments and Future Outlook
• 7.6. Johnson & Johnson
  • 7.6.1. Company Overview
  • 7.6.2. Company Mission
  • 7.6.3. Company Footprint
  • 7.6.4. Management Team
  • 7.6.5. Contact Details
  • 7.6.6. Green Chemistry Initiatives
• 7.7. Merck
  • 7.7.1. Company Overview
  • 7.7.2. Company Mission
  • 7.7.3. Company Footprint
  • 7.7.4. Management Team
  • 7.7.5. Contact Details
  • 7.7.6. Green Chemistry Initiatives
  • 7.7.7. Recent Developments and Future Outlook
• 7.8. Merck KGaA
  • 7.8.1. Company Overview
  • 7.8.2. Company Mission
  • 7.8.3. Company Footprint
  • 7.8.4. Management Team
  • 7.8.5. Contact Details
  • 7.8.6. Green Chemistry Initiatives
  • 7.8.7. Recent Developments and Future Outlook
• 7.9. Pfizer
  • 7.9.1. Company Overview
  • 7.9.2. Company Mission
  • 7.9.3. Company Footprint
  • 7.9.4. Management Team
  • 7.9.5. Contact Details
  • 7.9.6. Green Chemistry Initiatives
  • 7.9.7. Recent Developments and Future Outlook

8. CASE STUDY: BIG PHARMA INITIATIVES

• 8.1. Methodology and Key Parameters
• 8.2. Green Chemistry: Big Pharma Initiatives
  • 8.2.1. Johnson & Johnson
  • 8.2.2. Roche
  • 8.2.3. Merck
  • 8.2.4. Pfizer
  • 8.2.5. AbbVie
  • 8.2.6. AstraZeneca
  • 8.2.7. Novartis
  • 8.2.8. Bristol Myers Squibb
  • 8.2.9. GlaxoSmithKline

SECTION V: MARKET TRENDS

9. GREEN CHEMISTRY MARKET: OVERVIEW OF ONGOING MEGA TRENDS

• 9.1. Megatrends in the Green Chemistry Market
  • 9.1.1. Shift Towards Sustainable Drug Manufacturing
  • 9.1.2. Technological Advancements in Green Chemistry
  • 9.1.3. Integration of Continuous Flow Manufacturing in Green Chemistry
  • 9.1.4. Emphasis on Waste Valorization and Circular Chemistry
  • 9.1.5. Convergence of AI, Data Science and Green Chemistry
  • 9.1.6. Establishing Sustainability Metrices
  • 9.1.7. Increasing Adoption by Big-Pharma Companies
  • 9.1.8. Growing Regulatory Pressures

10. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

• 10.1. Market Drivers
• 10.2. Market Restraints
• 10.3. Market Opportunities
• 10.4. Market Challenges

SECTION V: APPENDIX

11. TABULATED DATA

12. LIST OF COMPANIES AND ORGANIZATIONS